Molecular Devices Introduces MetaMorph NX 2.5 Software with Comprehensive Neuronal Morphology Module

Targeted illumination support and fiber structure module expand family of image acquisition and analysis tools

„The Neurite Tracing Application Module automates many counting and quantification procedures that would take hours to perform manually,” said Dr Kenneth A. Barbee, Associate Professor, Drexel University School of Biomedical Engineering, Science & Health Systems. “The ability to accurately identify a multitude of neurite outgrowths that cross over, branch, and fragment is impressive.“

The Fiber Tracing Application Module uses a simple interface with powerful algorithms to differentiate fibers that cross over each other from fibers that branch from one another, quickly making sense of the entangled webs inherent to most fiber structures. The module supports a wide range of applications, from the study of elongated organisms, such as C. elegans and bacteria, to cytoskeleton investigations and angiogenesis analyses.

Version 2.5 of the MetaMorph NX Software offers a direct interface to Andor Technology‘s Mosaic and FRAPPA targeted illumination devices. A calibration wizard and ribbon-based workflow lead researchers from setup through completion of a variety of applications, including FRAP, FRET, photoactivation, photobleaching, and uncaging of caged compounds.

MetaMorph NX Software Version 2.5 will be showcased at Neuroscience 2012, October 13-17, in New Orleans. For more information please visit: www.metamorph.moleculardevices.com

About Molecular Devices, LLC
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics

Molecular Devices is committed to the continual development of innovative solutions for life science applications. The Company is headquartered in Silicon Valley with offices around the globe.

For more information about the complete product portfolio, visit www.moleculardevices.com

Contacts:
At Molecular Devices
Jennifer McKie
Vice President, Global Marketing
Tel: +1 408 747 1700
Email:jennifer.mckie@moldev.com

Media contact
Katie Odgaard
Zyme Communications
Tel: +44 (0) 7787 502 947
Email:katie.odgaard@zymecommunications.com
Twitter: zymecomms